Literature DB >> 9392700

Hepatitis B virus infection.

W M Lee1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9392700     DOI: 10.1056/NEJM199712113372406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  571 in total

Review 1.  Recent advances: hepatology.

Authors:  M McCarthy; M L Wilkinson
Journal:  BMJ       Date:  1999-05-08

2.  Humoral and cellular immunogenecity of DNA vaccine based on hepatitis B core gene in rhesus monkeys.

Authors:  Z H Huang; H Zhuang; S Lu; R H Guo; G M Xu; J Cai; W F Zhu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 3.  Treatment of chronic hepatitis B: new antiviral therapies.

Authors:  F Yao; R G Gish
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

4.  Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

Authors:  Christopher P Desmond; Silvana Gaudieri; Ian R James; Katja Pfafferott; Abha Chopra; George K Lau; Jennifer Audsley; Caroline Day; Sarah Chivers; Adam Gordon; Peter A Revill; Scott Bowden; Anna Ayres; Paul V Desmond; Alexander J Thompson; Stuart K Roberts; Stephen A Locarnini; Simon A Mallal; Sharon R Lewin
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

5.  Hepatitis B.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12

6.  In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90.

Authors:  J Hu; D Anselmo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Viral replication modulated by synthetic peptide derived from hepatitis B virus X protein.

Authors:  Chang-Zheng Song; Qing-Wei Wang; Chang-Cheng Song; Zeng-Liang Bai
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 8.  Hepatocellular carcinoma: epidemic and treatment.

Authors:  Jill Allen; Alan Venook
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

9.  Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.

Authors:  Reiichiro Kuwahara; Ryukichi Kumashiro; Hiroto Inoue; Ryo Tanabe; Eisuke Tanaka; Teruko Hino; Tatsuya Ide; Yuriko Koga; Michio Sata
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

10.  Targeting hepatitis B virus antigens to dendritic cells by heat shock protein to improve DNA vaccine potency.

Authors:  Qin-Long Gu; Xue Huang; Wen-Hong Ren; Lei Shen; Bing-Ya Liu; Si-Yi Chen
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.